Cargando…
Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization
The current clinical care of glioblastomas leaves behind invasive, radio‐ and chemo‐resistant cells. We recently identified mammary‐derived growth inhibitor (MDGI/FABP3) as a biomarker for invasive gliomas. Here, we demonstrate a novel function for MDGI in the maintenance of lysosomal membrane integ...
Autores principales: | Le Joncour, Vadim, Filppu, Pauliina, Hyvönen, Maija, Holopainen, Minna, Turunen, S Pauliina, Sihto, Harri, Burghardt, Isabel, Joensuu, Heikki, Tynninen, Olli, Jääskeläinen, Juha, Weller, Michael, Lehti, Kaisa, Käkelä, Reijo, Laakkonen, Pirjo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554674/ https://www.ncbi.nlm.nih.gov/pubmed/31068339 http://dx.doi.org/10.15252/emmm.201809034 |
Ejemplares similares
-
CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity
por: Filppu, Pauliina, et al.
Publicado: (2021) -
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours
por: Pulkka, Olli‐Pekka, et al.
Publicado: (2018) -
Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors
por: Puputti, Marjut, et al.
Publicado: (2009) -
Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness
por: Ylivinkka, Irene, et al.
Publicado: (2017) -
Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer
por: Sihto, Harri, et al.
Publicado: (2012)